OREX : Analysis & Opinions

  1. Better Access to VIVUS' Qsymia - Analyst Blog

    July 3, 2013
    VIVUS announced initial availability of Qsymia
  2. How Many Stocks in this Industry Could Tumble Into Bankruptcy?

    November 21, 2012
    Declaring bankruptcy has one clear benefit. It allows management to restructure a business without worrying about near-term ...
  3. Vivus Misses 3Q Estimates - Analyst Blog

    November 8, 2012
    Vivus Inc. (VVUS) reported a loss of 40 cents per share in the third quarter of 2012, wider than the Zacks Consensus Estimate ...
  4. CHMP Negative on Vivus' Qsiva - Analyst Blog

    October 22, 2012
    The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recently did not recommend ...
  5. Vivus Expects European Setback - Analyst Blog

    September 25, 2012
    Vivus Inc. (VVUS) recently announced that it expects the European Medicines Agency's (EMA) Committee for Medicinal Products ...
  6. Vivus Launches Obesity Drug Qsymia - Analyst Blog

    September 20, 2012
    Vivus Inc. (VVUS) recently announced the launch of its obesity drug, Qsymia, in the US following the US Food and Drug Administration's ...
  7. Buy or Sell? Wednesday's Winners: GWRE, OREX

    September 5, 2012
    Among the biggest winners in Wednesday's early trading are Guidewire Software (Nasdaq: GWRE) and Orexigen Therapeutics (Nasdaq: ...
  8. Arena Cuts Loss, Sales Climb - Analyst Blog

    August 14, 2012
    Arena Pharmaceuticals Inc. (ARNA) suffered a loss (excluding special items) of 12 cents per share in the second quarter of ...
  9. Glory for Vivus After Arena - Analyst Blog

    July 18, 2012
    Following a dry spell of thirteen years, the US Food and Drug Administration (FDA) approved two obesity drugs in the space ...
  10. Arena Seeks Approval in Switzerland - Analyst Blog

    July 13, 2012
    Close on the heels of the US approval of its weight loss drug lorcaserin HCl (US trade name: Belviq), Arena Pharmaceuticals, ...
  11. Second Time Lucky for Arena's Belviq - Analyst Blog

    June 29, 2012
    It proved to be second time lucky for Arena Pharmaceuticals, Inc. (ARNA) and Japanese entity Eisai Inc. with the companies ...
  12. Nutrisystem Still Searching For Sustainability

    March 12, 2012
    Nutrisystem's membership weakness is a worrisome sign.
  13. Vivus Tries A New Path

    September 21, 2011
    Vivus takes a more pragmatic approach to getting Qnexa to market.
  14. 6 Overbought Stocks To Watch

    September 21, 2011
    Let's take a look at a few stocks that have recently entered overbought territory because these could be candidates for a ...
  15. Fattening Up A Portfolio While Slimming Down

    June 1, 2011
    With the numbers of overweight and obese people growing globally, investors may want to consider stocks on the front lines ...
  16. Arena's New Data Doesn't Change Obesity Pill Outlook

    May 30, 2011
    Arena's new data isn't new and doesn't address the company's biggest issues.
  17. December's Healthcare Winners and Losers

    January 5, 2011
    Check out December's best and worst Healthcare Stocks.
  18. FDA To Obesity Drugs: Drop Dead

    September 20, 2010
    An FDA panel knocks down yet another would-be obesity drug.
  19. Orexigen Finds A Cautious Partner

    September 3, 2010
    Orexigen gets the going rate for an obesity drug with low expectations.
  20. Five Must-Ask Questions Before Taking The IPO Bait

    May 16, 2008
    IPOs often make great discussion but lousy investments. Learn how to avoid getting burned.
Investing News
  1. What $200,000 Will Buy In The Atlanta Real Estate Market

    Atlanta housing prices are up from last year, but they're still lower than the national median. ...
  2. Bubble Bursting? Only For Biotech & Internet Stocks

    The recent sluggish performance of U.S. stocks is leading some market watchers to question ...
  3. What $300,000 Will Buy In The Riverside/San Bernardino Real Estate Market

    The median list price for the San Bernardino/Riverside, Calif. market is $292,800, up 24.6% ...
  4. What Is Worse Than Being At Risk?

    You may have heard the old adage: “What is worse than being lost? Not knowing you are lost.” ...
  5. Can Paying Off Your Mortgage Early Hurt Your Net Worth?

    Saving your money and making double or even triple payments on a mortgage may sound productive, ...
  6. What $250,000 Will Buy In The Phoenix Real Estate Market

    The number of real estate listings in the Phoenix-Mesa market has increased more than 45% since ...
Trading Center